Active	Status	Sponsor type	Region	Phase	Filter
15 Active 1 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gedaly, Roberto
NCT03321656: Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile	Recruiting	2/3	78	US	Tacrolimus, Envarsus XR	Roberto Gedaly, Veloxis Pharmaceuticals	End Stage Renal Disease	03/25	03/26
NCT03284242: A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients	Completed	1	9	US	Treg, regulatory T cells	Roberto Gedaly, Novartis Pharmaceuticals	End Stage Renal Disease, Kidney Transplant	04/24	04/24
NCT04774484: High-Intensity Interval Training and Regulatory T Cells	Withdrawn	N/A	150	US	High Intensity Interval Training	Francesc Marti	End Stage Renal Disease	06/26	06/26
Rendulic, TrisAnn
NCT03321656: Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile	Recruiting	2/3	78	US	Tacrolimus, Envarsus XR	Roberto Gedaly, Veloxis Pharmaceuticals	End Stage Renal Disease	03/25	03/26
Braden, Sabrina
NCT03321656: Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile	Recruiting	2/3	78	US	Tacrolimus, Envarsus XR	Roberto Gedaly, Veloxis Pharmaceuticals	End Stage Renal Disease	03/25	03/26
Noehren, Brian
NCT03364647: The Effect of Various Strength Training Protocols in ACL Reconstructed Participants	Completed	N/A	55	US	Arm A - blood flow restriction training, Arm B - standard of care	Brian W. Noehren, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Anterior Cruciate Ligament (ACL) Tear, Physical Therapy	10/23	10/23
BRAINS, NCT04554212: Blood Flow Restriction Training After Patellar INStability	Recruiting	N/A	78	US	Blood Flow Restriction Training, Sham Blood Flow Restriction Training	Caitlin Conley, The Cleveland Clinic	Patellar Dislocation, Knee Injuries, Leg Injury, Wounds and Injuries	06/25	06/25
RIFLE, NCT05274022: Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture	Recruiting	N/A	60	US	Standard of Care Physical Therapy Program, Speed Walking Intervention	Brian W. Noehren, U.S. Army Medical Research and Development Command	Femoral Fracture, Tibial Fractures	07/25	07/25
NCT04774484: High-Intensity Interval Training and Regulatory T Cells	Withdrawn	N/A	150	US	High Intensity Interval Training	Francesc Marti	End Stage Renal Disease	06/26	06/26
Valvi, Deepa
NCT03321656: Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile	Recruiting	2/3	78	US	Tacrolimus, Envarsus XR	Roberto Gedaly, Veloxis Pharmaceuticals	End Stage Renal Disease	03/25	03/26
TEAMMATE, NCT05033548: Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient	Terminated	N/A	246	US		CareDx	Transplant	02/23	07/23
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
NCT04774484: High-Intensity Interval Training and Regulatory T Cells	Withdrawn	N/A	150	US	High Intensity Interval Training	Francesc Marti	End Stage Renal Disease	06/26	06/26
OLP-II, NCT05940857: US National OCS Liver Perfusion (OLP) Registry	Recruiting	N/A	100000	US	OCS Liver	TransMedics	Liver Transplant	10/31	10/31
Marti, Francesc
NCT04774484: High-Intensity Interval Training and Regulatory T Cells	Withdrawn	N/A	150	US	High Intensity Interval Training	Francesc Marti	End Stage Renal Disease	06/26	06/26